| 10/28/26 |
Eli Lilly (LLY) |
retatrutide for Diabetes Mellitus, Type II |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/26/26 |
Corcept Therapeutics (CORT) |
Lifyorli for Ovarian Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/26/26 |
Leads Biolabs |
LBL-024 for Neuroendocrine Tumors (NET) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/26/26 |
Coherus Oncology (CHRS) |
Loqtorzi for Non-Small Cell Lung Cancer (NSCLC) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
| 10/26/26 |
Merck & Co (MRK) |
Keytruda for Uterine (Endometrial) Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |